Trial Profile

The Effects of Nitric Oxide for Inhalation on the Development of Chronic Lung Disease in Pre-term Infants

Status: Completed

Phase of Trial: Phase III

Latest Information Update: 21 Jan 2022

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Nitric oxide (Primary) ; Nitrogen
Indications Bronchopulmonary dysplasia
Focus Therapeutic Use
Sponsors Ikaria Holdings; Mallinckrodt Inc.

Most Recent Events

03 Nov 2016 Status changed from active, no longer recruiting to completed.
21 May 2015 Planned End Date changed from 1 Mar 2015 to 1 Jun 2015, according to ClinicalTrials.gov record.
25 May 2014 New trial record

You need to be a logged in or subscribed to view this content Request demo (opens in a new window)

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com